Retreatment with rituximab for membranous nephropathy with persistently elevated titers of anti-phospholipase A2 receptor antibody

KIDNEY INTERNATIONAL

ELSEVIER SCIENCE INC

1. European Research Council [ERC-2012 ADG_20120314, 322947]
2. Seventh Framework Programme of the European Community (European Consortium for High-Throughput Research in Rare Kidney Diseases) [2012-305608]
3. European Research Council (ERC) [322947] Funding Source: European Research Council (ERC)